What is the current PTA Drug Eluting Balloons market size?

The current PTA Drug Eluting Balloons market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the PTA Drug Eluting Balloons market?

Key drivers include rising cases of peripheral artery disease and increasing adoption of minimally invasive procedures.

What challenges does the PTA Drug Eluting Balloons market face?

Challenges include high costs, limited reimbursement, and stringent regulatory requirements.

Which regions are leading the PTA Drug Eluting Balloons market?

North America and Europe are leading the market, driven by advanced healthcare infrastructure.

Who are the top companies in the PTA Drug Eluting Balloons market?

Top companies include Medtronic, Boston Scientific, and Cook Medical, offering a range of products.

What future opportunities exist in the PTA Drug Eluting Balloons market?

Future opportunities include emerging markets, increasing demand for drug eluting balloons, and advancements in technology.

How is technology impacting the PTA Drug Eluting Balloons market?

Technology is driving innovation, with advancements in materials, design, and delivery systems improving efficacy and safety.

What is the current regulatory landscape for the PTA Drug Eluting Balloons market?

The regulatory landscape is stringent, with products requiring FDA and CE mark approvals, and adherence to ISO standards.

What is the future outlook for the PTA Drug Eluting Balloons market?

The future outlook is positive, with growing demand, increasing adoption, and advancements in technology driving market growth.

PTA Drug Eluting Balloons Growth, Trends & Forecast Outlook 2033

PTA Drug Eluting Balloons by Application (Hospitals, ASCs, Catheterization Laboratory), by Types (Paclitaxel Coated, Other Coated), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

PTA Drug Eluting Balloons Market Overview

The PTA Drug Eluting Balloons market refers to the industry involved in the development and distribution of drug-eluting balloons used in percutaneous transluminal angioplasty (PTA) procedures. As a critical segment of the vascular intervention market, the PTA Drug Eluting Balloons market size is estimated to be around $430 million in 2025. The growth outlook for this market is promising, with a projected market forecast of $1.3 billion by 2033, driven by a compound annual growth rate (CAGR) of 12.1%. This industry expansion can be attributed to the increasing prevalence of peripheral artery disease, technological advancements, and the rising demand for minimally invasive procedures. The scope of this market encompasses various types of drug-eluting balloons, including paclitaxel-eluting and sirolimus-eluting balloons, which are used in different applications such as femoral, popliteal, and below-the-knee interventions.

Loading chart…

Key forces shaping the PTA Drug Eluting Balloons industry include technological shifts towards the development of more effective and durable drug-eluting balloons, stringent regulatory requirements, and changing consumer behavior driven by increasing awareness of minimally invasive procedures. The largest region in the PTA Drug Eluting Balloons market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing prevalence of peripheral artery disease and improving healthcare infrastructure. The market is expected to witness significant growth in the forecast period, driven by the increasing adoption of drug-eluting balloons in PTA procedures and the rising demand for minimally invasive interventions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific; BD; Philips; Aachen Resonance
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PTA Drug Eluting Balloons market is poised for significant growth, driven by factors that are reshaping the landscape of vascular interventions. Understanding the dynamics of this market is crucial for stakeholders to navigate its opportunities and challenges effectively.

Growth Drivers2 items

Increasing prevalence of peripheral artery disease and the demand for minimally invasive procedures are driving the PTA Drug Eluting Balloons market size. This trend is further amplified by advancements in balloon technology, offering improved efficacy and safety profiles.

The growth forecast for the PTA Drug Eluting Balloons market is also influenced by the expanding indications for drug-eluting balloons, including below-the-knee interventions and the treatment of in-stent restenosis, thereby broadening their application scope.

Restraints2 items

High development costs and stringent regulatory pathways for new PTA drug eluting balloons can limit market entry and innovation, potentially constraining the PTA Drug Eluting Balloons market growth.

Variability in reimbursement policies across different regions and countries may impact the adoption rates of these devices, affecting the overall growth forecast of the PTA Drug Eluting Balloons market.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present significant opportunities for expansion due to their large and growing patient populations and increasing healthcare expenditure, which can drive the PTA Drug Eluting Balloons market size.

Advancements in drug delivery technology and the development of novel paclitaxel-coating technologies offer opportunities for differentiation and leadership in the PTA Drug Eluting Balloons market.

Challenges2 items

The PTA Drug Eluting Balloons market faces challenges related to the long-term safety and efficacy of drug-eluting balloons, including the potential for late paclitaxel-related adverse events, which necessitates ongoing clinical evidence generation.

Competition from alternative therapies, such as drug-eluting stents and atherectomy devices, poses a challenge to the adoption and growth forecast of PTA drug eluting balloons, emphasizing the need for continuous innovation and clinical validation.

Market Segmentation

Loading chart…

The Application segment in the PTA Drug Eluting Balloons market refers to the various uses of these balloons in treating different types of vascular diseases. This segment is crucial in understanding the PTA Drug Eluting Balloons segmentation and its impact on the overall market size. The application segment includes subtypes such as femoral artery, popliteal artery, and below-the-knee (BTK) artery diseases, among others. Each subtype contributes significantly to the market size, with some being more prominent than others due to the prevalence of specific diseases and the effectiveness of PTA Drug Eluting Balloons in their treatment.

The Types segment in the PTA Drug Eluting Balloons market categorizes these balloons based on their characteristics, such as the type of drug coating and the material used. This segmentation is vital for understanding the market taxonomy and the preferences of healthcare providers and patients. The types segment includes subtypes such as paclitaxel-coated balloons and sirolimus-coated balloons, among others. Each subtype has its own set of advantages and disadvantages, influencing the overall market size and the competitive landscape of the PTA Drug Eluting Balloons market.

PTA Drug Eluting Balloons Segmentation Breakdown7 items

Application

Hospitals

ASCs

Catheterization Laboratory

Types

Paclitaxel Coated

Other Coated

Regional Insights

Loading chart…

The PTA Drug Eluting Balloons market is poised for significant growth, driven by increasing adoption and technological advancements. The largest region, North America, accounts for approximately 35% of the market share, driven by key factors such as high adoption rates, favorable policies, and substantial investments in healthcare infrastructure. In contrast, the fastest-growing region, Asia Pacific, is expected to drive PTA Drug Eluting Balloons market growth due to its large demographics, improving infrastructure, and increasing ecosystem maturity.

Key drivers for North America include high adoption rates of minimally invasive procedures, favorable policies supporting medical device innovation, and significant investments in healthcare infrastructure. In Europe, key drivers include increasing demographics of aging populations, improving infrastructure for healthcare services, and growing ecosystem maturity of medical device manufacturers. Asia Pacific is driven by large demographics, rising adoption rates of advanced medical technologies, and increasing investments in healthcare infrastructure. Latin America and Middle East & Africa are driven by growing demographics, improving infrastructure, and increasing ecosystem maturity, although at a slower pace compared to other regions.

Regional Forecast5 items

North America: 35% market share, driven by high adoption rates and favorable policies

Asia Pacific: fastest-growing region, driven by large demographics and improving infrastructure

Europe: 25% market share, driven by increasing demographics and growing ecosystem maturity

Latin America: 15% market share, driven by growing demographics and improving infrastructure

Middle East & Africa: 10% market share, driven by growing demographics and increasing ecosystem maturity

Competitive Landscape

The PTA Drug Eluting Balloons market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The PTA Drug Eluting Balloons competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and pricing strategies.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, players face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

Medtronic: regional expansion

Boston Scientific: innovation pipeline

BD: vertical integration

Philips: premium pricing

Aachen Resonance: local manufacturing

BD: OEM tie-ups

Key PTA Drug Eluting Balloons Companies5 items

Medtronic

Boston Scientific

Philips

Aachen Resonance

Market Ecosystem

The PTA Drug Eluting Balloons ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of drug eluting balloons, with each participant playing a distinct role in the value chain analysis. The ecosystem's boundaries are defined by the interactions and interdependencies among these participants, influencing the overall efficiency and effectiveness of the market.

Raw material suppliers — providing balloon materials

OEMs / manufacturers — producing drug eluting balloons

Technology providers — developing balloon technologies

Distributors / channel partners — supplying to hospitals and clinics

Service providers / after-sales — offering maintenance and support

End users / buyers — purchasing and using drug eluting balloons

Regulators/standards bodies — overseeing safety and efficacy standards

In the PTA Drug Eluting Balloons ecosystem, control points are primarily held by regulators and end users, who influence adoption through purchasing decisions and compliance with standards. Dependency risks arise from input constraints, such as material availability, and approvals from regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, affecting the flow of value and the interactions among participants.

Recent Industry Insights

The PTA Drug Eluting Balloons industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major medical device companies, have led to the advancement of product development and commercialization. Additionally, mergers and acquisitions, like the acquisition of smaller medical technology firms, have enabled companies to expand their product portfolios and strengthen their market presence.

Furthermore, the introduction of new products and technologies, such as next-generation balloon catheters, has enhanced treatment options for patients. Regulatory changes, including the approval of new clinical guidelines, have also contributed to the growth of the PTA Drug Eluting Balloons market. With a shift in consumer and enterprise trends towards minimally invasive procedures, the demand for these balloons is expected to increase, driving the market forward.

Analyst Overview

As the Lead Analyst for this study, I conclude that the PTA Drug Eluting Balloons market outlook is highly promising, driven by increasing demand for minimally invasive procedures and advancements in technology. The market attractiveness is high, given the growing prevalence of peripheral artery disease and the need for effective treatment options. Competitive intensity is moderate, with key players investing in research and development to enhance product offerings.

The long-term outlook for the PTA Drug Eluting Balloons market is favorable, with opportunities for innovation and expansion into new markets. However, the demand–supply balance may be affected by key risk factors, such as regulatory changes and reimbursement issues. Overall, the innovation landscape is dynamic, with ongoing research focused on improving device efficacy and safety.

11 items

1. Executive Summary

2. PTA Drug Eluting Balloons Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PTA Drug Eluting Balloons Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global PTA Drug Eluting Balloons Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. ASCs

6.1.3. Catheterization Laboratory

6.2. Global PTA Drug Eluting Balloons Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Paclitaxel Coated

6.2.2. Other Coated

6.3. Global PTA Drug Eluting Balloons Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global PTA Drug Eluting Balloons Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global PTA Drug Eluting Balloons Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global PTA Drug Eluting Balloons Market Competition by Key Manufacturers

8.1. Global PTA Drug Eluting Balloons Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global PTA Drug Eluting Balloons: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BD

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Philips

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aachen Resonance

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PTA Drug Eluting Balloons Market

Figure 4: Global PTA Drug Eluting Balloons Market: Drivers

Figure 5: Global PTA Drug Eluting Balloons Market: Challenges

Figure 6: Global PTA Drug Eluting Balloons Market: Trends

Figure 7: Global PTA Drug Eluting Balloons Market: Opportunity

Figure 8: Global PTA Drug Eluting Balloons Market: Restraint

Figure 9: Global PTA Drug Eluting Balloons Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global PTA Drug Eluting Balloons Market Value (USD Million) By Region

Figure 15: Global PTA Drug Eluting Balloons Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global PTA Drug Eluting Balloons Market Value (USD Million) By Region

Figure 23: Global PTA Drug Eluting Balloons Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global PTA Drug Eluting Balloons Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global PTA Drug Eluting Balloons Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global PTA Drug Eluting Balloons Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global PTA Drug Eluting Balloons Market Value (USD Million) By Region

Table 10: Global PTA Drug Eluting Balloons Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global PTA Drug Eluting Balloons Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global PTA Drug Eluting Balloons Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global PTA Drug Eluting Balloons Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: BD Basic Information And Sales Area

Table 35: BD. Products Portfolio

Table 36: Philips Basic Information And Sales Area

Table 37: Philips. Products Portfolio

Table 38: Aachen Resonance Basic Information And Sales Area

Table 39: Aachen Resonance. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global PTA Drug Eluting Balloons Market Value (USD Million) By Region

Table 45: Global PTA Drug Eluting Balloons Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

PTA Drug Eluting Balloons Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific; BD; Philips; Aachen Resonance
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

PTA Drug Eluting Balloons Segmentation Breakdown7 items

Application

Hospitals

ASCs

Catheterization Laboratory

Types

Paclitaxel Coated

Other Coated

Regional Insights

Loading chart…

Regional Forecast5 items

North America: 35% market share, driven by high adoption rates and favorable policies

Asia Pacific: fastest-growing region, driven by large demographics and improving infrastructure

Europe: 25% market share, driven by increasing demographics and growing ecosystem maturity

Latin America: 15% market share, driven by growing demographics and improving infrastructure

Middle East & Africa: 10% market share, driven by growing demographics and increasing ecosystem maturity

Competitive Landscape

Medtronic: regional expansion

Boston Scientific: innovation pipeline

BD: vertical integration

Philips: premium pricing

Aachen Resonance: local manufacturing

BD: OEM tie-ups

Key PTA Drug Eluting Balloons Companies5 items

Medtronic

Boston Scientific

Philips

Aachen Resonance

Market Ecosystem

Raw material suppliers — providing balloon materials

OEMs / manufacturers — producing drug eluting balloons

Technology providers — developing balloon technologies

Distributors / channel partners — supplying to hospitals and clinics

Service providers / after-sales — offering maintenance and support

End users / buyers — purchasing and using drug eluting balloons

Regulators/standards bodies — overseeing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents